Pablo Javier M. F.
- Country
- Spain
- Department
- Hematology
Research Overview
- Phase I Evaluation of ABBV-525, a MALT1 Inhibitor, in Patients with B-Cell Malignancies
- Evaluation of ABBV-319 Pharmacokinetics, Safety, and Efficacy in Adults with Relapsed/Refractory Diffuse Large B-cell Lymphoma, Follicular Lymphoma, or Chronic Lymphocytic Leukemia
- Phase 3 Randomized Study of Tirabrutinib Versus Rituximab-Temozolomide in Relapsed/Refractory Primary Central Nervous System Lymphoma
Data & Insights
Has run more than one trial at 61 of 162 partner sites.
Specializations
Hematologic Malignancies
Pablo Mozas is involved in clinical research across a broad range of hematologic malignancies, with particular emphasis on acute myeloid leukemia, multiple myeloma, and lymphoid neoplasms. His trial activity also includes chronic lymphocytic leukemia, mantle cell lymphoma, diffuse large B-cell lymphoma, and myelodysplastic syndromes.
- Acute myeloid leukemia
- Multiple myeloma
- Chronic lymphocytic leukemia
- Diffuse large B-cell lymphoma
- Myelodysplastic syndromes
His work reflects sustained involvement in therapeutic development for relapsed, refractory, and newly diagnosed blood cancers, including immune-based and targeted treatment strategies.
Solid Tumors in Thoracic, Breast, and Genitourinary Oncology
His oncology portfolio includes extensive research in non-small cell lung cancer, small cell lung cancer, breast cancer, prostate cancer, urothelial carcinoma, and renal cell carcinoma. He is also active in studies of gastrointestinal cancers such as gastric cancer, colorectal cancer, pancreatic cancer, and hepatocellular carcinoma.
- Non-small cell lung cancer
- Breast cancer
- Prostate cancer
- Urothelial carcinoma
- Renal cell carcinoma
His clinical trial landscape is centered on advanced solid tumors, including biomarker-defined disease and metastatic settings where new systemic options are needed.
Autoimmune, Inflammatory, and Transplant-Related Disorders
Pablo Mozas is also engaged in trials addressing autoimmune disease and immune-mediated inflammatory disorders, including rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, Crohn's disease, and ulcerative colitis. His research scope extends to graft-versus-host disease and kidney transplant-related complications.
- Rheumatoid arthritis
- Psoriatic arthritis
- Systemic lupus erythematosus
- Crohn's disease
- Kidney transplant
These studies reflect involvement in therapies aimed at immune regulation, inflammatory control, and transplant preservation.
Cardiovascular, Renal, and Metabolic Medicine
His clinical research includes atherosclerotic cardiovascular disease, acute coronary syndrome, heart failure, atrial fibrillation, and pulmonary hypertension, alongside renal conditions such as chronic kidney disease, IgA nephropathy, and glomerulonephritis. He is also involved in studies of diabetes mellitus, obesity, and hypertriglyceridemia.
- Atherosclerotic cardiovascular disease
- Heart failure
- Chronic kidney disease
- IgA nephropathy
- Diabetes mellitus
His activity spans prevention and treatment domains in cardiometabolic disease, renal protection, and vascular risk reduction.
Liver Disease, Neurology, and Dermatology
Additional research interests include chronic liver disease, cirrhosis, primary biliary cholangitis, hepatitis B, and alcohol-related liver disease. He also contributes to trials in Alzheimer's disease, Parkinson's disease, migraine, and epilepsy, as well as atopic dermatitis, psoriasis, vitiligo, and alopecia areata.
- Chronic liver disease
- Primary biliary cholangitis
- Alzheimer's disease
- Parkinson's disease
- Atopic dermatitis
His portfolio shows therapeutic interest in chronic organ disease, neurodegeneration, and immune-driven skin conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.